In this paper, we describe our experience in the treatment of childhood empyema using urokinase. Patients' ages ranged from 2 to 12 years. Urokinase (dosage: 3,100 IU/kg/day) was diluted in normal saline to produce 1000 IU/ml (maximum dosage 100,000 IU in 100 ml of normal saline). After 2 hours, the clamped catheters were released and connected to water-seal suction at a negative pressure of 10 cm H2O. Pleural irrigations were continued once a day until thoracostomy tube output decreased to less than 10 ml/day (urokinase treatment mean duration: 11.5 days). The complete resolution of the chest effusion was assessed on chest ultrasound scan and radiographs. None of the patients experienced any side effects due to urokinase. It would now seem reasonable to advocate small chest tube thoracostomy and intrapleural urokinase as first-line treatment of pleural empyema in children, with surgery indicated as a secondaryintervention.

Once-daily intrapleural urokinase treatment of complicated parapneumonic effusion in pediatric patients / Bianchini, M. A.; Ceccarelli, P. L.; Repetto, P.; Durante, V.; Biondini, D.; Bergamini, Barbara Maria; Cacciari, A.. - In: TURKISH JOURNAL OF PEDIATRICS. - ISSN 0041-4301. - STAMPA. - 52:(2010), pp. 274-277.

Once-daily intrapleural urokinase treatment of complicated parapneumonic effusion in pediatric patients

BERGAMINI, Barbara Maria;
2010

Abstract

In this paper, we describe our experience in the treatment of childhood empyema using urokinase. Patients' ages ranged from 2 to 12 years. Urokinase (dosage: 3,100 IU/kg/day) was diluted in normal saline to produce 1000 IU/ml (maximum dosage 100,000 IU in 100 ml of normal saline). After 2 hours, the clamped catheters were released and connected to water-seal suction at a negative pressure of 10 cm H2O. Pleural irrigations were continued once a day until thoracostomy tube output decreased to less than 10 ml/day (urokinase treatment mean duration: 11.5 days). The complete resolution of the chest effusion was assessed on chest ultrasound scan and radiographs. None of the patients experienced any side effects due to urokinase. It would now seem reasonable to advocate small chest tube thoracostomy and intrapleural urokinase as first-line treatment of pleural empyema in children, with surgery indicated as a secondaryintervention.
52
274
277
Once-daily intrapleural urokinase treatment of complicated parapneumonic effusion in pediatric patients / Bianchini, M. A.; Ceccarelli, P. L.; Repetto, P.; Durante, V.; Biondini, D.; Bergamini, Barbara Maria; Cacciari, A.. - In: TURKISH JOURNAL OF PEDIATRICS. - ISSN 0041-4301. - STAMPA. - 52:(2010), pp. 274-277.
Bianchini, M. A.; Ceccarelli, P. L.; Repetto, P.; Durante, V.; Biondini, D.; Bergamini, Barbara Maria; Cacciari, A.
File in questo prodotto:
File Dimensione Formato  
Once daily intrapleural urokinase treatment of complicated parapneumonic effusion in pediatric patients.pdf

accesso aperto

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 126.92 kB
Formato Adobe PDF
126.92 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/644094
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 11
social impact